According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current revenue (TTM ) is A$0.17 Billion. In 2024 the company made a revenue of A$0.16 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.